Asset Details
Do you wish to reserve the book?
Low plasma serotonin linked to higher nigral iron in Parkinson’s disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Low plasma serotonin linked to higher nigral iron in Parkinson’s disease
Do you wish to request the book?
Low plasma serotonin linked to higher nigral iron in Parkinson’s disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Low plasma serotonin linked to higher nigral iron in Parkinson’s disease
2021
Overview
A growing body of evidence suggests nigral iron accumulation plays an important role in the pathophysiology of Parkinson’s disease (PD), contributing to dopaminergic neuron loss in the substantia nigra pars compacta (SNc). Converging evidence suggests this accumulation might be related to, or increased by, serotonergic dysfunction, a common, often early feature of the disease. We investigated whether lower plasma serotonin in PD is associated with higher nigral iron. We obtained plasma samples from 97 PD patients and 89 controls and MRI scans from a sub-cohort (62 PD, 70 controls). We measured serotonin concentrations using ultra-high performance liquid chromatography and regional iron content using MRI-based quantitative susceptibility mapping. PD patients had lower plasma serotonin (
p
< 0.0001) and higher nigral iron content (SNc:
p
< 0.001) overall. Exclusively in PD, lower plasma serotonin was correlated with higher nigral iron (SNc: r(58) = − 0.501,
p
< 0.001). This correlation was significant even in patients newly diagnosed (< 1 year) and stronger in the SNc than any other region examined. This study reveals an early, linear association between low serotonin and higher nigral iron in PD patients, which is absent in controls. This is consistent with a serotonin-iron relationship in the disease process, warranting further studies to determine its cause and directionality.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 692/617
/ 692/699
/ Aged
/ Female
/ High-performance liquid chromatography
/ Humanities and Social Sciences
/ Humans
/ Iron
/ Male
/ Parkinson Disease - diagnostic imaging
/ Parkinson Disease - drug therapy
/ Parkinson Disease - metabolism
/ Plasma
/ Science
/ Selective Serotonin Reuptake Inhibitors - pharmacology
/ Selective Serotonin Reuptake Inhibitors - therapeutic use
/ Serotonin and Noradrenaline Reuptake Inhibitors - metabolism
/ Serotonin and Noradrenaline Reuptake Inhibitors - pharmacology
/ Serotonin and Noradrenaline Reuptake Inhibitors - therapeutic use
/ Substantia Nigra - diagnostic imaging
/ Substantia Nigra - metabolism
/ Time
